Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 238-098-4 | CAS number: 14228-73-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to OECD TG 439 and in accordance with the Principles of Good Laboratory Practices (GLP).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- Remarks:
- Certain minor exceptions were noted but this had no overall impact to the study
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes
Test material
- Reference substance name:
- 1,4-bis[(2,3-epoxypropoxy)methyl]cyclohexane
- EC Number:
- 600-447-7
- Cas Number:
- 14228-73-0
- Molecular formula:
- C14 H24 O4
- IUPAC Name:
- 1,4-bis[(2,3-epoxypropoxy)methyl]cyclohexane
- Test material form:
- other: clear, colorless, semi-viscous liquid
- Details on test material:
- - Name of test material (as cited in study report): 1,4 Cyclohexanedimethanol Reaction Products with Epichlorohydrin
- Analytical purity: The purity of the test material was determined to be 9.5 area % 1,4-Cyclohexanedimethanol monoglycidiyl ether, 45.0 area %, 1,4-Cyclohexanedimethanol diglycidyl ether, and 25.0 area % of the reaction product of 1,4-cyclohexanedimethanol with 3 equivalents of epichlorohydrin by gas chromatography/flame ionization detector with tentative identification of the major components by nuclear magnetic resonance and gas chromatography mass spectrometry
- Impurities (identity and concentrations): no information available
- Lot number : Lot # 1H1050NZP1
- Expiration date of the lot/batch: March 05, 2015
Constituent 1
Test animals
- Species:
- other: reconstituted huma epidermis model
- Strain:
- not specified
- Details on test animals or test system and environmental conditions:
- not applicable
Test system
- Type of coverage:
- other: not applicable
- Preparation of test site:
- other: not applicable
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: not applicable
- Amount / concentration applied:
- not applicable
- Duration of treatment / exposure:
- 60 minutes
- Observation period:
- The skin irritation potential of the test substance was evaluated by measuring the relative cell viability in treated tissues at 42-hour post-exposure
incubation after a 60-minute exposure to the test substance. - Number of animals:
- not applicable
- Details on study design:
- Upon receipt of the EpiDerm™ (MatTek Corporation), the solutions were stored as indicated by the manufacturer. The EpiDerm™ tissues were stored at 2-8ºC until used. On the day of receipt, an appropriate volume of fresh EpiDerm™ EPI-100-NMM Maintenance Medium was pre-warmed to room temperature. Nine-tenths (0.9) mL of Maintenance Medium were aliquotted into the appropriate wells of each 6-well plate, which were pre-labeled to indicate the test or control substance. Each EpiDerm™ tissue was inspected for air bubbles between the agarose gel and Millicell® insert prior to opening the sealed package. There was no tissue with air bubbles accounting for greater than 50% of the Millicell® area used in the assay. The 24-well shipping containers were removed from the plastic bag and their surfaces were disinfected with 70% ethanol. An appropriate number of tissues were removed from the 24-well shipping plate and transferred to the 6-well plate containing Maintenance Media. The plates were placed into the incubator at 37±1ºC in a humidified atmosphere of 5±1% CO2 in air (standard culture
conditions) for 60±5 minutes. At the end of the incubation period, the inserts were transferred into wells containing fresh Maintenance Medium and incubated overnight (18 ±3 hours) to acclimate the tissues.
The test substance was added to a 1.0 mg/mL MTT (Sigma) solution in warm MTT Addition Medium to assess its ability to directly reduce MTT. Approximately 25 mg of the test substance were added to 1 mL of the MTT solution, and the mixture was incubated in the dark at 37ºC for approximately one hour. The negative control, 30 μL of sterile, calcium and magnesium free Dulbecco’s Phosphate Buffered Saline (CMF-DPBS), was tested concurrently. If the MTT solution color turned blue/purple, the test substance was presumed to have reduced the MTT. The test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was not observed to directly reduce MTT in the absence of viable cells.
Prior to performing the assay, the compatibility of the test substance with the nylon mesh was evaluated. Nylon meshes (Elko) were placed on a slide and 30 μL of the test substance was applied. A negative control, 30 μL of sterile, Calcium and Magnesium Free Dulbecco’s Phosphate Buffered Saline (CMF-DPBS) (Gibco, Lot # 1165768), was tested concurrently. The slides holding the treated meshes were placed into a Petri dish and incubated at standard culture conditions for 60±1 minutes. Using a microscope, each mesh was checked after 60 minutes of exposure to assess any interaction between the test substance and the mesh.
The test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was not observed to interact with the nylon mesh, and therefore a nylon mesh was used to aid in the spreading of the test substance after dosing the EpiDerm™ tissues.
The pH of the test substance was measured using pH paper (EMD Chemicals Inc.). Initially, the test substance was added to pH paper with a 0-14 pH range in 1.0 pH unit increments to approximate a narrow pH range. Next, the test substance was added to pH paper with a narrower range of 5-10 pH units with 0.5 pH unit increments, to obtain a more accurate pH value.
The definitive assay included a negative control and a positive control. The negative control was 30 μL of 1 sterile, CMF-DPBS (Gibco, Lot # 1165768) and the positive control was 30 μL of 5% Sodium Dodecyl Sulfate (SDS) (Sigma). The 5% SDS was prepared by adding SDS powder (Sigma, Lot 069k0344v) in sterile deionized water (Quality Biological, Lot 719494). Both the positive and negative controls were tested in triplicate, and at the same exposure time as the test substance (60±1 minutes).
Definitive Test - The test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was tested in one valid definitive trial. After the overnight incubation for 18±3 hours, the 6-well plates containing the EpiDerm™ tissues were removed from the incubator and placed at room temperature for at least 5 minutes prior to dosing. The EpiDerm™ tissues were treated in triplicate with the test substance for 60±1 minutes. Thirty microliters of the test substance were applied to each of three tissues at 1 minute intervals per tissue. A nylon mesh was placed gently over the dose to spread the test substance. If necessary, the mesh was gently pressed down to ensure even spreading. The EpiDerm™ tissues were tested in triplicate with the positive or negative control for 60±1 minutes. Thirty microliters of each control were applied to each of three tissues at 1 minute intervals per tissue. Immediately after control administration onto the tissue, a nylon mesh was placed gently over the dose to spread the negative and positive controls. The plates with dosed tissues were kept in the laminar flow hood until the last tissue was dosed. After the last tissue was dosed, all of plates were transferred to the incubator for 35±1 minutes at
standard culture conditions. After 35 minutes, all of the plates were removed from the incubator, placed into the laminar flow hood and kept at room temperature until the exposure period was completed for the first dosed tissue.
After 60 ± 1 minutes exposure, the EpiDerm™ tissues were rinsed with sterile, CMF-DPBS by filling and emptying the tissue insert 15 times. A stream of CMF-DPBS was directed onto the tissue surface. For the control substances where a mesh was used, the mesh was carefully removed with forceps (if necessary) after the 5th rinse. After the removal of the mesh, the rinsing procedure of the tissue continued for 10 times. After the 15th rinse, each of the 3 inserts per treatment group (test substance, positive, and negative control) was completely submerged, gently swirled, and the rinse media were added to a beaker containing approximately 150 mL of CMF-DPBS and specifically assigned/labelled for each treatment group; this procedure was repeated three times for each insert of each treatment group. Finally, the tissues were rinsed once more on the inside and outside of the tissue insert with sterile CMF-DPBS from the wash bottle, and the excess CMF-DPBS was decanted. The bottom of the tissue insert was blotted on sterile paper towels and the tissue surface was carefully blotted with sterile cottontipped applicators to remove any excess moisture. The tissue surface was visually observed for residual test substance or excess moisture using a dissecting scope. Once the rinsing was complete, the tissue inserts were transferred to new 6-well plates containing 0.9 mL of fresh Maintenance Medium. The tissues were then placed into the incubator at standard culture conditions for a post-treatment expression incubation of 24±1 hours.
After the 24±1 hour post-treatment expression incubation, the 6-well plates were removed from the incubator. The tissues were transferred into new 6-well plates pre-filled with 0.9 mL fresh Maintenance Medium warmed to approximately 37ºC. The tissues were placed back into the incubator for an additional 18±1 hours post-treatment incubation at standard culture conditions.
MTT Test - A 1.0 mg/mL solution of MTT prepared in warm MTT Addition Medium was prepared no more than 2 hours before use. Three hundred microliters of MTT solution were added to each designated well of a pre-labeled 24-well plate. At the end of the 42±2 hour incubation period, the EpiDerm™ tissues were blotted on sterile paper towels to remove any excessive moisture and then transferred to the appropriate well containing 0.3 mL of MTT solution. The plates were incubated at 37±1ºC for approximately 3±0.1 hours at standard culture conditions. After the MTT incubation, the EpiDerm™ tissues were submerged into 150 mL of CMF-DPBS, swirled, and the rinse media dumped out of the Millicell®. This process was performed three times. The tissues were then blotted on sterile paper towels, and transferred to a pre-labelled 24-well plate containing 2.0 mL of isopropanol in each designated well. The plates were covered with paraffin film, and shaken for at least 2 hours at room temperature to extract the MTT. At the end of the extraction period, the inserts were pierced with forceps and gently agitated up and down in their individual wells containing the isopropanol used for extraction. The tissue was then lifted to allow the extract to flow back into the well from which the insert was removed, and the insert was discarded. The extract solutions were mixed (homogenized by pipetting up and down three times) and two x 200 μL aliquots were transferred to the appropriate wells of a 96-well plate. Six x 200 μL aliquots of isopropanol were added to the wells designated as blanks. The absorbance at 570 nm (OD570) of each well was measured with a Molecular Devices Vmax plate reader, with AUTOMIX function selected.
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- other: other: % viability
- Value:
- 11.1
- Remarks on result:
- other:
- Remarks:
- Basis: mean. Time point: 60 minutes and a 42 hour post exposure incubation. Reversibility: no data. (migrated information)
- Other effects / acceptance of results:
- The skin irritation potential of the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was evaluated by measuring the relative cell viability in treated EpiDerm™ tissues after a 60-minute exposure and a 42-hour post-exposure incubation.
The mean OD570 of the negative control, CMF-DPBS, was 2.074. The mean viability of the positive control, 5% SDS, was 5.11%. The standard deviation calculated from individual percent tissue viabilities of the 3 identically treated replicates was < 18% for the positive control and negative control. Since the acceptance criteria were met, the assay was considered valid.
The test substance was not observed to directly reduce MTT in the absence of viable cells.
Based upon the results of this assay, the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was predicted to be irritating, and thus would require an R38 label.
Any other information on results incl. tables
SIT Results Using the EpiDerm™ Skin Model
Test substance | Concentration | % viable | R38 irritant | pH |
1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin | Undiluted | 11.1 | yes | 5.5 |
5% SDS (positive control) | NA | 5.11 | yes | NA |
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 (irritant) based on GHS criteria
- Conclusions:
- Based upon the results of this assay, the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was predicted to be a skin irritant according to the prediction model validated by ECVAM, and endorsed by the ECVAM Scientific Advisory Committee (ESAC) at its 29th meeting, held on 4-5th November 2008. The protocol met the requirements of the OECD guideline, “In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method” (TG 439). Accordingly, the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, would be labeled a skin irritant, “R38” within the context of the European Risk Phrase system or a skin irritant, Category 2 as per the Guidance to Regulation (EC) No. 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures (2012)
- Executive summary:
The MatTek Corporation’s EpiDerm ™ reconstituted human epidermis model was used to assess the potential skin irritation of the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin (1,4-CHDM DGE). The skin irritation potential of the test substance was evaluated by measuring the relative cell viability in treated tissues at 42-hour post-exposure incubation after a 60-minute exposure to the test substance, according to the Protocol for: In vitro EpiDerm™ skin irritation test (EPI-200-SIT) evaluated and validated by the European Centre for the Validation of Alternative Methods (ECVAM). The protocol met the requirements of the OECD guideline, “In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method” (TG 439).
The test substance, 1,4-Cyclohexanedimethanol, reaction products with epichorohydrin, resulted in a 11.1% cell viability and was predicted to be a skin irritant. Results of the positive control and negative control met the criteria of a valid assay. Accordingly, the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, would be labeled a skin irritant, “R38” within the context of the European Risk Phrase system or a skin irritant, Category 2 as per the Guidance to Regulation (EC) No. 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures (2012).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.